New online CBT program shows promise for teen emotional disorders

NCT ID NCT04182061

Completed Symptom relief Sponsor: Universidad Nacional de Educación a Distancia Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested an internet-based cognitive behavioral therapy (CBT) program called AMTE for adolescents with anxiety and depression. Sixty teens were randomly assigned to either the online program or a control group. The goal was to see if the program could reduce symptoms of anxiety and depression and improve emotional well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Internet-delivered cognitive behavioral therapy (CBT) program called AMTE
What this could lead to: If it works, this could provide a convenient, online treatment option for teens struggling with anxiety and depression, making therapy more accessible.
What could go wrong: This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The program is also only available in Spanish, limiting its reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGORAPHOBIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agoraphobia anxiety disorder Depression depressive disorder dysthymic disorder generalized anxiety disorder major depressive disorder mental disorder panic disorder separation anxiety disorder social phobia specific phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDER DEPRESSIVE DISORDER EMOTIONAL DISORDER

Contacts and locations

Locations

Bonifacio Sandín

Madrid, Madrid, 28040, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.